Tom Polen | Leader's Agenda Podcast | Life Sciences Innovation & Corporate Responsibility скачать в хорошем качестве

Tom Polen | Leader's Agenda Podcast | Life Sciences Innovation & Corporate Responsibility

Subscribe at https://bit.ly/LeadersAgendaYT Learn More at https://leadersagenda.com/ Listen on Spotify: https://open.spotify.com/show/4k8spID... 𝗛𝗼𝘄 𝗱𝗶𝗱 𝗕𝗗 𝘀𝗵𝗼𝗿𝘁𝗲𝗻 𝗮 𝟯-𝘆𝗲𝗮𝗿 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗰𝘆𝗰𝗹𝗲 𝘁𝗼 𝟯 𝗺𝗼𝗻𝘁𝗵𝘀 𝘄𝗵𝗶𝗹𝗲 𝘀𝗰𝗮𝗹𝗶𝗻𝗴 𝘂𝗽 𝗶𝘁𝘀 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗳𝗿𝗼𝗺 𝟴 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝘀 𝗶𝗻 𝗮 𝘆𝗲𝗮𝗿 𝘁𝗼 𝟭𝟮 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝘁𝗲𝘀𝘁𝘀 𝙚𝙖𝙘𝙝 𝙢𝙤𝙣𝙩𝙝? 𝐓𝐡𝐞 𝐚𝐧𝐬𝐰𝐞𝐫 from BD CEO, Tom Polen, 𝐦𝐢𝐠𝐡𝐭 𝐬𝐮𝐫𝐩𝐫𝐢𝐬𝐞 𝐲𝐨𝐮! Listen to our latest #LeadersAgenda Podcast episode with Tom Polen, the CEO of BD! In this deep-dive conversation, you'll gain an insider's view of the mobilization and fast action that the Life Sciences industry underwent to fight a global pandemic, as well as some of the unique learnings and strategies that Tom has adopted throughout his career, shaping him into the leader that he is today. #LeadersAgenda host, Tarja Huuskonen works with Tom Polen to explore not only the macro forces that are shaping Life Sciences innovation, but the societal themes that are forcing a new conversation about corporate responsibility, leadership integrity, inclusion, and cultural renewal. Continue the conversation with us, Tom Polen, and BD on social media:   / actionforresults     / afrinc_     / actionforresults   https://www.actionforresults.com/ --------------------------------------------------------- Tom Polen is chairman, chief executive officer and president of BD (Becton, Dickinson and Company), an innovative global medical technology company headquartered in Franklin Lakes, New Jersey. Since taking the leadership reins in early 2020, he has focused the organization’s BD 2025 strategy around three pillars—Grow, Simplify, and Empower—which drive and accelerate the innovation of advanced, cutting-edge technologies like smart connected devices, and the high performance of a diverse team of 70,000 associates who approach their work with a growth mindset. He puts a strong emphasis on the impact BD’s associates make by doing things The BD WAY every day and fulfilling the company’s purpose of advancing the world of health. Polen originally came to BD in 1999 through the acquisition of an early phase start-up. In 2004, he joined Baxter Healthcare, where his last role was a leading Baxter’s Injectable Pharmaceuticals business. He returned to BD as president of BD Preanalytical Systems in 2009; as segment president, BD Medical, Polen led the $12 billion acquisition of CareFusion in 2015, spearheading the company’s expansion into informatics and digital health solutions. Shortly after leading the strategy for the $24 billion acquisition of C. R. Bard, Inc. in 2017, he was named president and chief operating officer. Tom Polen became chief executive officer in January 2020 and chairman of the board of directors in April 2021. Polen serves on the board of directors of AdvaMed, where he is a member of the T&R Committee. He is also on the boards of directors of the Hackensack Meridian Health Foundation and the Hackensack Meridian Health Center for Discovery and Innovation (CDI), and is a member of the American Heart Association CEO Roundtable. He is active in support of Children’s Tumor Foundation, as well as a number of national and local associations committed to helping patients with breast cancer. Polen earned his bachelor’s degree from the Salisbury University of Maryland and a master’s degree in business administration from Johns Hopkins University.